<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20180807040733N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-11-20</date_registration>
      <primary_sponsor>Shahid Beheshti University of Medical Sciences</primary_sponsor>
      <public_title>Efficacy measurement of Intravenous Ibuprofen versus Intravenous Ketorolac in Patient Renal Colic Admittend in Emergency Department</public_title>
      <acronym></acronym>
      <scientific_title>Efficacy measurement of Intravenous Ibuprofen versus Intravenous Ketorolac in Patient Renal Colic Admittend in Emergency Department</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2016-03-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>240</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/33136</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Block Random Metod Hase Used In This Reasearch. By A Proffesional Person Guidence In Random Blocks In 6 Size Was Planed By A Proffesional Person Guidence In Clinical Traial Study Metodology .Therefore 40 Prepared Blocks Was Specified According to This Method Pationts Were Divided Into Two Groups Threated By Ibuprofen(group A) &amp; Threated By Ketorolac (group B), Blinding description: Participats, Reasercher, Injector Nurse &amp; Data Collecting liable have been Blind In This Reaserch.
The preparation of drug pakage was done by an individual who did not have any role inthe research process at all,30 mg of Ketorolac was poured into 100ml of normal saline &amp;800mg of Ibuprofen was poured in 100ml of another normal saline and placed in two group A &amp; B and prepared For injection.From here on, a Nurse injector who was a person other than the person preparing the pakage ,without any information on the contents of the pack , it only injected serum containing randomized into roups based on grouping alone , patients ,with Full Justification for theirtreatment , after completing informed consent about participation in the research, Without any information about the type of drug ,they were interviewed by the researcher after the end of injection at15,30,&amp;60 minutes. The main investigator on the type of injected drug was blind and unaware, This information was collected and evaluated based on the checklist.Actually, except for the package-maker who had no role in the  reseach process,the rest of the group was kept blind until the last stage.</study_design>
      <phase>3</phase>
      <hc_freetext>Renal Colic.</hc_freetext>
      <i_freetext>Intervention group:.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Final result of reaserch will be published as articl in the Emergency medicinemagazine of the Medical academy of Shahid Beheshty Univercity.

When:
This article will be published in the last thre months of 1397 &amp; thence it will be available.

To whom:
Generally all researchers,specially Emergency medicine phisitians ,Urologists , chemists, students &amp; also pharmaceutic companies can access issues of this research with observation of respective protocol.

Conditions:
The stady data,s access is passible by getting permission of guidance prof &amp;councillar &amp; accurate observation of principle committec rules &amp;my coordination to ward research &amp;similar studies &amp; check&amp; contrast its results with related studies.

Where to obtain:
You must to refer to prof Saeed Safari  master of Emergency medicine of Shahid Beheshty Univercity&amp;my councillor &amp;statistics prof who has complete authority in terms of this issue to receive data &amp;documentsof this research.He presents at Shohadaye Tajrish Hospital on tuesdays &amp; at the research office of the medical school of the medical science academy of Shahid Beheshty Univercity the rest of week.phone number prof safari is 09128251535 , Email address is safari266@gmail.com

How to obtain:
One who want to access this research,s data has to send his/her request to prof safari ,s e-mail address transpicuously &amp; at least after time process 2 weeks can receivethis study,s data with prof,s agreement &amp; approval. Email address is :safari266@gmail.com

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Khaghan Mohammadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>NO.13, Shahid Frotani Alley, Dehkhoda St, Motahhari Ave, Karaj Town</address>
        <city>Karaj</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۳۱۴۵۹۵۴۹۱۸</zip>
        <telephone>+98 26 3449 3136</telephone>
        <email>drkhaghanmohammadi@sbmu.ac.ir</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Khaghan Mohammadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>NO.13, Shahid Frotani Alley, Dehkhoda St, Motahhari Ave, Karaj Town</address>
        <city>Karaj</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۳۱۴۵۹۵۴۹۱۸</zip>
        <telephone>+98 26 3449 3136</telephone>
        <email>drkhaghanmohammadi@sbmu.ac.ir</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Every Adalts with Renal Colic Diagnosis
Age:Between 18 to 65  years old</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Having Alergy to Ketorolac &amp; Ibuprofen
Noncooperation to Determine Severity Of Pain by VAS
Peregnancy
Having background of Heart disease &amp; Hypertention disease
Advanced Systemic disease, Malignancy,&amp; Chronic Hepatic disease
Psychiatric &amp; Noroulogic disease
Use of NSAID at 6 hours ago</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>N20</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Calculus of kidney and ureter</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: </i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Curative Success (change of visual analogue scale till atleast 3 score). Timepoint: Incipience of Stady , 15th minute, 30th, 60th. Method of measurement: Visual Analogue Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahid Beheshti University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2016-09-27</approval_date>
        <contact_name>Ethics commitee of Shahid Beheshti University of Medical Sciences</contact_name>
        <contact_address>7thFloor,BldgNo.2,Shahid Beheshti Univercity Medical School, Arabi St,Velenjak Ave,Tehran Town Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
